Patent: 9,995,746
✉ Email this page to a colleague
Summary for Patent: 9,995,746
Title: | Rapid dual direct fluorescent antibody assay for the identification of Bacillus antrhacis |
Abstract: | In this application is described a method for rapidly and accurately identifying B. anthracis in a sample by simultaneously detecting the presence of cell wall antigen and capsule antigen in the same sample culture grown under capsule inducing conditions. Other uses and advantages of the method of the invention are described herein. |
Inventor(s): | Abshire; Teresa (Frederick, MD), Ribot; Wilson J (Hanover, PA) |
Assignee: | The United States of America, as represented by the Secretary of the Army (Washington, DC) |
Application Number: | 15/125,910 |
Patent Claims: | see list of patent claims |
Details for Patent 9,995,746
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Emergent Biodefense Operations Lansing Llc | BIOTHRAX | anthrax vaccine adsorbed | Injection | 103821 | 11/12/1998 | ⤷ Try a Trial | 2040-01-28 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |